Si-bone, inc. announces new technology add-on payment for breakthrough adult spinal deformity treatment

Santa clara, calif., april 19, 2022 (globe newswire) -- si-bone, inc., (nasdaq: sibn) a silicon valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the centers for medicare and medicaid services (cms) has proposed a new technology add-on payment (ntap) for the ifuse bedrock granite™ implant. the granite implant is intended to provide sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. the granite implant was awarded breakthrough device designation by the fda and is anticipated to receive regulatory clearance this year. in designating the granite implant as a breakthrough device, the fda determined that it provides for more effective treatment of an irreversibly debilitating condition than the current standard of care. the ntap program, which recognizes new technologies that provide substantial clinical improvement over already available therapies, is designed to support timely access to such innovative technologies for medicare beneficiaries.
SIBN Ratings Summary
SIBN Quant Ranking